R1 RCM (NASDAQ:RCM) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS

R1 RCM (NASDAQ:RCM) posted its quarterly earnings results on Tuesday. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04), Briefing.com reports. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $656.80 million during the quarter, compared to analysts’ expectations of $640.93 million. The business’s revenue was up 14.7% compared to the same quarter last year.

R1 RCM Stock Up 0.1 %

Shares of RCM traded up $0.01 during mid-day trading on Wednesday, hitting $14.28. 1,345,833 shares of the company’s stock were exchanged, compared to its average volume of 3,479,946. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. The company has a market cap of $6.03 billion, a price-to-earnings ratio of -142.70 and a beta of 0.84. The stock’s 50-day moving average is $14.18 and its 200-day moving average is $13.28. R1 RCM has a fifty-two week low of $8.87 and a fifty-two week high of $15.12.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on RCM shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $15.00 target price on shares of R1 RCM in a research note on Monday, July 22nd. Truist Financial reduced their target price on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating on the stock in a research note on Thursday, August 8th. TD Cowen reiterated a “hold” rating and issued a $14.30 target price (down from $20.00) on shares of R1 RCM in a report on Monday, August 5th. Stephens downgraded shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 1st. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $14.30 price objective on shares of R1 RCM in a report on Friday, October 4th. Thirteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.